Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  London Stock Exchange  >  GlaxoSmithKline plc    GSK

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M GBP Estimates in M GBP
Fiscal Period December 201220132014201520162017
Sales26 43126 50523 00624 08524 81125 530
Operating income (EBITDA)9 4158 8838 0457 2087 7838 299
Operating profit (EBIT)8 3308 0156 5946 1016 2676 753
Pre-Tax Profit (EBT)6 6926 6472 9686 4344 6115 057
Net income4 5655 6282 7565 8412 5073 006
EPS (PNC)91,511156,713061,270,5
Dividend per Share (PNC)74,078,080,091,682,280,6
Yield5,38%5,67%5,82%6,66%5,98%5,86%
Announcement Date02/06/2013
12:01pm
02/05/2014
12:00pm
02/04/2015
03:18pm
---
Finances - Leverage
Actuals in M GBP Estimates in M GBP
Fiscal Period December 201220132014201520162017
Debt14 03712 64514 37710 89512 42512 540
Finance------
Operating income (EBITDA)9 4158 8838 0457 2087 7838 299
Leverage
(Debt/EBITDA)
1,49x1,42x1,79x1,51x1,60x1,51x
Capital Expenditure1 0511 1881 1882 1411 6751 436
Book Value Per Share (BVPS)120 PNC146 PNC87,6 PNC123 PNC121 PNC106 PNC
Cash Flow per Share87,7 PNC149 PNC108 PNC94,9 PNC104 PNC123 PNC
Announcement Date02/06/2013
12:01pm
02/05/2014
12:00pm
02/04/2015
03:18pm
---
Balance Sheet Analysis
Assessed data source :
© 2015 Thomson Reuters
Advertisement
Financial Ratios

Size 2015e 2016e
Capitalization 66 889 M GBP -
Entreprise Value (EV) 77 784 M GBP 79 314 M GBP
Valuation 2015e 2016e
PER (Price / EPS) 10,6x 22,4x
Capitalization / Revenue 2,78x 2,70x
EV / Revenue 3,23x 3,20x
EV / EBITDA 10,8x 10,2x
Yield (DPS / Price) 6,66% 5,98%
Price to book (Price / BVPS) 11,2x 11,4x
Profitability 2015e 2016e
Operating Margin (EBIT / Sales) 25,3% 25,3%
operating Leverage (Delta EBIT / Delta Sales) - 0,90x
Net Margin (Net Profit / Revenue) 24,3% 10,1%
ROA (Net Profit / Asset) 15,6% 8,13%
ROE (Net Profit / Equities) 82,6% 68,2%
Rate of Dividend 70,3% 134%
Balance Sheet Analysis 2015e 2016e
CAPEX / Sales   8,89% 6,75%
Cash Flow / Sales (Taux d'autofinancement) 19,2% 20,4%
Capital Intensity (Assets / Sales) 1,56x 1,24x
Financial Leverage (Net Debt / EBITDA) 1,51x 1,60x
Price Earning Ratio
EPS & Dividend